Unicycive Therapeutics, Inc. (UNCY)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-08-25 | Aggarwal Gaurav | director | C | 652,900 | — | — |
| 2025-08-25 | Aggarwal Gaurav | director | C | 652,900 | — | — |
| 2025-02-18 | Aggarwal Gaurav | director | C | 1,400,000 | — | — |
| 2025-02-18 | Aggarwal Gaurav | director | C | 1,400,000 | — | — |
| 2024-10-09 | Aggarwal Gaurav | director | C | 5,500,000 | — | — |
| 2024-10-09 | Aggarwal Gaurav | director | C | 5,500,000 | — | — |
| 2023-07-11 | Aggarwal Gaurav | director | C | 3,470,152 | — | — |
| 2023-07-11 | Jermasek Douglas | officer | M | 104,612 | — | — |
| 2023-07-11 | Gupta Pramod | officer | M | 41,845 | — | — |
| 2023-07-11 | Gupta Shalabh K. | director | M | 104,612 | — | — |
| 2022-07-15 | Schiller Brigitte | director | M | 26,738 | 0 | $0 |
| 2022-05-16 | Schiller Brigitte | director | P | 15,000 | 0.83 | $12,375 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-12 8-K
- 2026-08-12 10-Q
- 2026-07-28 4/A
- 2026-07-28 4/A
- 2026-07-08 SCHEDULE 13G/A
- 2026-07-02 8-K
- 2026-07-01 144
- 2026-06-22 DEFA14A
- 2026-06-22 8-K
- 2026-06-15 EFFECT
- 2026-06-15 4/A
- 2026-06-15 4/A
- 2026-06-15 4/A
- 2026-06-15 4/A
- 2026-06-15 4/A
- 2026-06-15 4/A
- 2026-06-11 UPLOAD
- 2026-06-11 CORRESP